MARKER THERAPEUTICS, INC. (MRKR) Shareholders’ equity 2017–2025
MARKER THERAPEUTICS, INC. (MRKR) shareholders’ equity at each fiscal year-end, per SEC filings.
$16.8MFY2025 · since FY2017: $3.7M → $16.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $16.8M | -9.5% |
| FY2024 | $18.6M | +32.1% |
| FY2023 | $14.1M | -28.3% |
| FY2022 | $19.6M | -55.4% |
| FY2021 | $44.0M | +60.9% |
| FY2020 | $27.3M | -38.0% |
| FY2019 | $44.1M | -25.7% |
| FY2018 | $59.3M | +1522.2% |
| FY2017 | $3.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice